2Feldman ME, Apsel B, Uotila A, et al. Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORCI and mTORC2 [J]. PLoSBiol, 2009,7(2 ) : e38.
3Sehenone S, Brullo C, Musumeei F,et at. ATP-eompetitive inhibitors of roTOR:an update [J]. Curr Med Chem,2011,18 (20) :2995- 3014.
4Martinez G,delongh RU. The lens epithelium in ocular health and disease [J].Int J Bioehem Cell Biol,2010,42(12) : 1945-1963.
5Milani P, Pierro L, Pece A, et al. Retinal photoreceptor focal disrup- tion secondary to accidental Nd:YAG laser exposure [ J ].Int Oph- thalmol, 2011,31 ( 5 ) : 409-412.
6Benjamin D, Colombi M, Moroni C, et al. Rapamycinpasses the torch: a new generation of mTOR inhibitors [J ]. Nat RevDrug Discov, 2011, 10( 1 1 ) : 868-880.
8Hoang B,Frost B,Shi YJ,et al. Targeting TORC2 in multiple myeloma with a new roTOR kinase inhibitor [J]. Blood,2010,116 (22) : 4560-4568.
9Angell JE, Lindner D J, Shapiro PS, et al.Identification of GRIM-19, a novel cell death-regulatory gene induced by theinterferon-beta and retinoic acid combination,using a genetic approach [ J ]. J Biol Chem, 2000,275 ( 43 ) : 33416-33426.
10Kalvakolanu DV, Nallar SC, Kalakonda S. Cytokine-induced tumor- suppressors : a GRIM story [ J ]. Cytokine, 2010,52( 1-2 ) : 128-142.
